search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Join the integrated innovation platform at Thailand LAB & Bio Asia Pacific 2024


The 14th edition of Thailand LAB INTERNATIONAL will be held from 11-13 September 2024 at EH 102-104, BITEC, Bangkok. This event will be co-located with Bio Asia Pacifi c, FutureCHEM INTERNATIONAL, Health & Innovation Asia, and Healthy Food Asia, creating a comprehensive platform for the laboratory, life sciences, biotechnology, chemicals, food, and healthcare industries.


This is the fi nal opportunity to secure a spot at one of the year’s most anticipated laboratory events. Space is fi lling up quickly, so act now to connect with industry leaders, showcase innovations, and expand business networks. Contact the team to get the best deal in prime locations.


With fi ve show profi les co-located, Thailand LAB INTERNATIONAL


2024 offers unparalleled opportunities for networking, partnering, and collaborating. Explore the latest advancements in laboratory technology, life sciences, biotechnology, chemicals, health innovation, and the healthy food sector. This event aims to be an innovation hub, a stage for knowledge sharing, and a marketplace, providing a platform for businesses to thrive and professionals to gain insights into the latest trends and technologies.


Stay tuned for online pre-registration. Mark your calendar and register early to secure your place at this global gathering of experts and innovators.


More information online: ilmt.co/PL/5B6v and ilmt.co/PL/JRAW 62691pr@reply-direct.com


Leading CRO expands into South Korea


Avance Clinical, the award-winning CRO for biotechs, has announced the opening of new clinical operations in Seoul, South Korea.


Avance Clinical CEO, Yvonne Lungershausen, explained that the expansion is in response to growing demand from US biotechs in later phases and CRO partners seeking the region’s scientifi c expertise and patient populations.


“Our recent presentation of the GlobalReady drug development solution to over 75 Korean biotechs and pharmaceutical companies highlighted the need for local clinical operations with a global pathway,” Lungershausen stated. “There is clear demand for a mid- sized, agile CRO with in-house regulatory expertise and a strong track record in advancing high-quality clinical programs.”


The new South Korean operations will provide a strategic presence for Avance Clinical’s CRO partners conducting multi-regional or global trials. Korean biotechs will also benefi t from Avance’s clinical services in Australia and the United States as they advance their drug development programs.


“Avance Clinical teams in APAC, Europe, and the US deliver world-class quality data and seamless geographic expansions to accelerate drug development programs,” said Lungershausen. “Our study data is accepted by major regulatory authorities including the MFDS, FDA, and TGA.”


“Biotechs need a partner that can deliver high-quality data quickly, accepted by the US FDA and other regulatory bodies. Supported by our in-house global regulatory affairs team, we navigate regulatory complexities with confi dence,” she added.


Avance Clinical’s GlobalReady Site Partnership Network, with over 2,000 qualifi ed sites worldwide, ensures maximum effi ciency for biotech clients’ trials. The company is focused on accelerating drug development from preclinical stages to Phase III, using a streamlined multi-phase and multi-region process through its GlobalReady program.


More information online: ilmt.co/PL/05oW 62715pr@reply-direct.com


Advancements in kirigami hydrogels opens new horizons for flexible materials


Researchers at Tokyo University of Agriculture and Technology (TUAT) have developed new methods for creating fi nely structured, soft, fl exible, and expandable materials called hydrogels. Their work, published in the journal Science and Technology of Advanced Materials, extends the emerging fi eld of ‘kirigami


hydrogels.’ In this technique, patterns are cut into a thin fi lm, which then swells into complex hydrogel structures upon exposure to water.


Hydrogels consist of a network of water- attracting (hydrophilic) molecules, enabling their structure to swell signifi cantly when water is incorporated into the molecular network. Researchers Daisuke Nakagawa and Itsuo Hanasaki used an initially dry fi lm composed of cellulose nanofi bres, a natural material that forms much of the plant cell wall structure.


Using laser processing, they cut intricate structures into the fi lm before adding water, allowing the fi lm to swell. The kirigami pattern design increases the fi lm’s width when stretched longitudinally, demonstrating an auxetic property. This auxetic behaviour, characterised by an increase in width when stretched, emerges if the fi lm’s thickness suffi ciently increases when wetted.


A Kirigami pattern of the hydrogel (top) and the hydrogel swollen from dry state (bottom). Credit: Tokyo University of Agriculture and Technology


Hanasaki explained: “Kirigami, meaning the cut design of paper, was originally intended for thin sheets. Our two-dimensional auxetic mechanism manifests when the fi lm’s thickness is adequate, creating a three-dimensional hydrogel structure upon


swelling. It’s convenient to store it dry before use, rather than maintaining the same water content level as the hydrogel.”


The auxetic property is maintained during cyclic loading, which causes the hydrogel to adapt to another structural state, making it crucial for designing intelligent materials. These adaptive hydrogels have potential applications in robotic technologies, where they can respond fl exibly when interacting with objects. They may also be used in soft switches, sensor components, and medical applications, such as tissue engineering, wound dressings, and drug delivery systems.


The TUAT team’s advancement in kirigami hydrogels signifi cantly expands future hydrogel applications. Hanasaki concluded: “Keeping the designed characteristics while showing adaptivity to the environmental condition is advantageous for developing multifunctionality.”


The research was published in Science and Technology of Advanced Materials (STAM)


More information online: ilmt.co/PL/MbYo 62734pr@reply-direct.com


New Australian office supports growing LIMS business


The Autoscribe Australian team.


Autoscribe Informatics Pty Ltd, the Australian arm of Autoscribe Informatics, is has announced its relocation to new offi ces in West Lakes Adelaide, in response to the growing demand for its Laboratory Information Management System (LIMS) solutions across the Asia Pacifi c region. Headed by Jodie Poole, Director of Asia Pacifi c, with over 23 years of experience in IT and laboratory informatics, the move signifi es a strategic step towards better serving its expanding clientele.


“We’re witnessing a steady rise in LIMS adoption across Australasia,” remarked Jodie. “Our transition to West Lakes not only furnishes us with a conducive workspace but also positions us optimally to attract top-tier talent and propel further growth. The location’s connectivity within Australia and the wider Asia Pacifi c is a signifi cant advantage.”


Autoscribe’s Australian division caters to a diverse array of industries throughout the Asia Pacifi c, including veterinary, medical research, defence, environmental, biobanking, pharmaceutical, manufacturing, and contract laboratories, ensuring a varied and interesting portfolio of projects.


Simon Wood, Product Manager at Autoscribe Informatics, highlighted the adaptability of the Matrix Gemini LIMS, stating: “The versatility of the Autoscribe product allows seamless integration across a multitude of applications. Our recent merger with Xybion fortifi es our preclinical LIMS offerings and augments our QMS solution with predictive compliance risk analysis. Together, the Xybion/Autoscribe alliance delivers comprehensive expertise and an array of solutions, enabling end-to-end laboratory digitisation and automation across diverse industries.”


More information online: ilmt.co/PL/15YL 62716pr@reply-direct.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48